These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23793109)

  • 1. Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort study.
    Mok CC; Chan PT; Ho LY; Yu KL; To CH
    Medicine (Baltimore); 2013 Jul; 92(4):217-222. PubMed ID: 23793109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
    Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study.
    Manzano-Gamero V; Pardo-Cabello AJ; Vargas-Hitos JA; Zamora-Pasadas M; Navarrete-Navarrete N; Sabio JM; Jáimez-Gámiz L; Ríos-Fernandez R; Ortego-Centeno N; Ayala-Gutierrez MM; de Ramón E; Colodro-Ruíz A; Micó-Giner L; Castillo-Palma MJ; Robles-Marhuenda Á; Luna-Del Castillo JD; Jiménez-Alonso J;
    Int J Rheum Dis; 2018 Nov; 21(11):2028-2035. PubMed ID: 28593703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients.
    Islabão AG; Mota LMH; Ribeiro MCM; Arabi TM; Cividatti GN; Queiroz LB; Andrade DC; Sakamoto AP; Trindade VC; Novak GV; Molinari BC; Campos LM; Aikawa NE; Pereira RMR; Terreri MT; Magalhães CS; Marini R; Gomes HR; Silva MF; Oliveira SK; Sztajnbok FR; Sacchetti SB; Bica BE; Sena EG; Moraes AP; Santos MC; Robazzi TC; Spelling PF; Scheibel IM; Cavalcanti AS; Naka EN; Guimarães LJ; Santos FP; Sampaio MC; Bonfá E; Silva CA;
    Autoimmun Rev; 2020 Dec; 19(12):102693. PubMed ID: 33164791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.
    Serrano R; Pons-Estel GJ; Espinosa G; Quintana RM; Reverter JC; Tassies D; Monteagudo J; Cervera R
    Lupus; 2020 Aug; 29(9):1050-1059. PubMed ID: 32536318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome.
    Grika EP; Ziakas PD; Zintzaras E; Moutsopoulos HM; Vlachoyiannopoulos PG
    J Rheumatol; 2012 Mar; 39(3):516-23. PubMed ID: 22247356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups.
    Mok CC; Mak A; Chu WP; To CH; Wong SN
    Medicine (Baltimore); 2005 Jul; 84(4):218-224. PubMed ID: 16010206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study.
    Ricard L; Laurent C; Papo M; Deriaz S; Catano J; Alamowitch S; Kayem G; Chasset F; De Moreuil C; Boffa JJ; Gerotziafas G; Elalamy I; Bornes M; Maillot F; Audemard-Verger A; Planche V; Ballot E; Fain O; Mekinian A
    Joint Bone Spine; 2022 Mar; 89(2):105297. PubMed ID: 34656751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis.
    Bundhun PK; Soogund MZS; Huang F
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):212. PubMed ID: 29879927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.